Silencing the EZH2 gene by RNA interference reverses the drug resistance of human hepatic multidrug-resistant cancer cells to 5-Fu

We demonstrate the relationship between EZH2 and multidrug-resistance in hepatic cancer for the first time. EZH2 may become a new target for gene therapy to reverse multidrug-resistance in hepatic cancer.